Emprime Therapeutics Inc

Biotechnology company · Rochester, New York, United States

Emprime Therapeutics Inc is a biotechnology company headquartered in Rochester, New York, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $314,363 in total, most recently in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Emprime Therapeutics at a glance

Typebiotechnology company

HeadquartersRochester, New York, United States

Employees (self-reported, 2025)3

What does Emprime Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $314,363 in total (2025). NIH funding came from the National Heart, Lung, and Blood Institute.

Frequently asked questions about Emprime Therapeutics

Where is Emprime Therapeutics headquartered?

Emprime Therapeutics Inc is headquartered in Rochester, New York, United States.

What does Emprime Therapeutics do?

Emprime Therapeutics Inc is a biotechnology company.

Similar companies

Vyriad, Inc.Rochester, Minnesota, United States
Imanis Life Sciences, LLCRochester, Minnesota, United States
LifEngine Animal Health Laboratories IncRochester, Minnesota, United States
OyaGen Inc.Rochester, New York, United States
Clerio Vision Inc.Rochester, New York, United States
WNT Scientific LLCRochester, New York, United States
Retinal Solutions LLCRochester, Michigan, United States
Advanced Gene Transfer Company, Inc.Rochester, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences